Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 60

Results For "NIT"

6327 News Found

HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin
Healthcare | May 19, 2026

HLL Lifecare marks diamond jubilee with release of special Rs. 60 commemorative coin

Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development


Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization
Supply Chain | May 19, 2026

Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization

Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets


Pfizer promotes Ashish Doshi as Director at IITM RP, Chennai
People | May 19, 2026

Pfizer promotes Ashish Doshi as Director at IITM RP, Chennai

Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations


Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge
News | May 19, 2026

Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge

Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels


SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer
Clinical Trials | May 19, 2026

SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer

The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients


Alivus Life Sciences posts steady FY26 growth as margins surge past guidance
News | May 19, 2026

Alivus Life Sciences posts steady FY26 growth as margins surge past guidance

The company reported free cash flow of Rs. 2,590 Mn for FY26


FDA expands Enhertu use in early HER2-positive breast cancer
Drug Approval | May 19, 2026

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease


Lupin debuts in Dow Jones best-in-class indices for ESG performance
News | May 19, 2026

Lupin debuts in Dow Jones best-in-class indices for ESG performance

The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index


Medix Biochemica unleashes $5 million expansion to secure future of IVD supply chain
R&D | May 19, 2026

Medix Biochemica unleashes $5 million expansion to secure future of IVD supply chain

The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030


Teva study exposes major diagnosis gap in Tardive Dyskinesia
R&D | May 19, 2026

Teva study exposes major diagnosis gap in Tardive Dyskinesia

According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD